Findings using genetic models were recapitulated in mice treated with the drug fingolimod (FTY720), which targets S1PR1, and in ulcerative colitis patients treated with the drug ozanimod, also an S1PR1 modulator. This evidence concerns the gene S1PR1 and ulcerative colitis.